ASMI welcomes its newest member: Endeavour Consumer Health
31 July 2015 -The Australian Self Medication Industry (ASMI) today welcomed its newest member, Endeavour Consumer Health.
ASMI Executive Director, Deon Schoombie, said: "ASMI welcomes Endeavour Consumer Health and we look forward to working with them.
"ASMI helps its members to successfully navigate changes in the external environment. As businesses continue to expand their over-the-counter (OTC)/complementary medicines businesses and unprecedented reform occurs in the regulatory environment, ASMI membership has never been more important.
"Endeavour Consumer Health's membership of ASMI recognises the prominent role ASMI plays as the voice of the non-prescription medicines industry," Schoombie added.
Jennifer Luke, Executive Director at Endeavour Consumer Health, said ASMI was "a great fit for our business".
"ASMI provides us with invaluable advice and information, training and education," she said.
"We are proud to become a member of ASMI, who lead the way in advancing consumer health through responsible self-care."
About Endeavour Consumer Health
Endeavour Consumer Health is a trans-Tasman business dedicated to providing its retail partners and their customers with affordable, high-quality health and personal care products. The business was formed in 2014 from the amalgamation of Symbion Consumer Products in Australia and the consumer division of EBOS Healthcare in New Zealand and Australia.
Endeavour Consumer Health is responsible for marketing and selling respected Australian brands including Chemmart® and Pharmacy Choice®, Faulding®, Lice Blaster® and Allersearch®, and represents international brands including Attends®. In New Zealand, Endeavour Consumer Health owns market-leading brand Anti-Flamme and represents several international brands including Ansell, Philips AVENT, Deep Heat® and BioCeuticals®.
The Australian Self-Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines (CM). ASMI members make up 85 per cent of the $4bn Non-Prescription Medicines market. Membership totals 50 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to advance consumer health through responsible self-care. This means driving a viable and responsible industry and empowering the consumer with evidence-based products and information with the aim of improving health and wellbeing. To find out more about ASMI or how to become an ASMI member, please visit (www.asmi.com.au).
For more information or to arrange a media interview, please contact: